Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

iRhythm Holdings (IRTC) Receivables - Other (2015 - 2017)

iRhythm Holdings (IRTC) reported Receivables - Other of $700000.0 for Q3 2017, up 13.64% year-over-year from $616000.0 in Q3 2016, and up 40.0% on a QoQ basis from $500000.0 in Q2 2017.

iRhythm Holdings (IRTC) has 3 years of Receivables - Other data on file, last reported at $700000.0 in Q3 2017.

  • Quarterly Receivables - Other rose 13.64% year-over-year to $700000.0 in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $700000.0 (up 13.64% YoY) and the FY2016 annual result came in at $400000.0, up 9.29% from the prior year.
  • Receivables - Other advanced to $700000.0 in Q3 2017 per IRTC's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $700000.0 in Q3 2017 and bottomed at $366000.0 in Q4 2015.
  • The 3-year median for Receivables - Other is $558000.0 (2016), against an average of $541166.7.
  • The widest annual swing landed in 2016, when Receivables - Other advanced 9.29%; it then increased 13.64% in 2017.
  • Tracing IRTC's Receivables - Other over 3 years: stood at $366000.0 in 2015, then grew by 9.29% to $400000.0 in 2016, then jumped by 75.0% to $700000.0 in 2017.
  • Per Business Quant, the three latest IRTC Receivables - Other figures stand at $700000.0 (Q3 2017), $500000.0 (Q2 2017), and $665000.0 (Q1 2017).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 iRhythm Holdings 3.55 Bn 3.00 Bn 141.35 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 700,000.00
Sep 30, 2017 700,000.00
Jun 30, 2017 500,000.00
Jun 30, 2017 500,000.00
Mar 31, 2017 665,000.00
Mar 31, 2017 665,000.00
Dec 31, 2016 400,000.00
Dec 31, 2016 400,000.00
Sep 30, 2016 616,000.00
Sep 30, 2016 616,000.00
Dec 31, 2015 366,000.00
Dec 31, 2015 366,000.00